Skip to content

Clinical trials

Phase 3 Ischemic Stroke trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Ischemic Stroke Phase: Phase 3 Country / region: United Kingdom Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20091
20121
20141
20161
20172
20181
20191
20231
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed4
Terminated2
Unknown status2
Active, not recruiting1
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bayer1
CSL Behring1
H. Lundbeck A/S1
Janssen Research & Development, LLC1
NHS Greater Glasgow and Clyde1
NoNO Inc.1
Pharmazz, Inc.1
University Hospital of North Norway1
University of Zurich1
Universitätsklinikum Hamburg-Eppendorf1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Ischemic Stroke10
Stroke7
Acute Coronary Syndrome1
Atherosclerosis1
Atrial Fibrillation1
Cardiovascular Diseases1
Cerebrovascular Disorders1
Coronary Artery Disease1
Heart Diseases1
Heart Failure1

Trials

Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.